Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed2
Other3

Role Distribution

Principal Investigator4
Other Roles1
PI Rate80%

Activity Timeline

Clinical Trials (5)

Trajectory Analysis of NLR and Its Association With Efficacy of Immunochemotherapy in ESCC.
ChemotherapyEsophageal Squamous Cell CarcinomaImmunotherapy
PrincipalinvestigatorStart date: 2022-11-01
NCT05637580Completed
Pathological Tumor and Lymph Node Responses After Neoadjuvant Immunochemotherapy in Initially-unresectable NSCLC
ChemotherapyImmunotherapyNon Small Cell Lung Cancer+1 more
StudydirectorStart date: 2019-05-20
NCT05596890Phase 2Unknown
Patient-reported Outcomes in Preoperative Immunochemotherapy/Radiotherapy-treated Esophageal Cancer Patients
Esophageal Squamous Cell CarcinomaImmunotherapyPatient-reported Outcomes
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

yuankai shi, MD

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Related
17 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungCancer of EsophagusEsophageal Squamous Cell Carcinoma
Similarity Score13%

Lei Li, M.D.

Peking Union Medical College Hospital

Related
46 trials

Shared therapeutic areas:

Drug TherapyImmunotherapy
Similarity Score9%

howard Safran, MD

Brown University

Related
16 trials

Shared therapeutic areas:

Cancer of EsophagusCarcinoma, Non-Small-Cell Lung
Similarity Score9%

Ajay Goel, PhD

City of Hope Medical Center

Related
24 trials

Shared therapeutic areas:

Cancer of EsophagusEsophageal Squamous Cell Carcinoma
Similarity Score9%

Lin Shen, MD

Peking University Cancer Hospital & Institute

Related
20 trials

Shared therapeutic areas:

Cancer of EsophagusEsophageal Squamous Cell Carcinoma

Worked with same sponsors:

Sichuan Cancer Hospital and Research Institute
Similarity Score9%

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

Related
21 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungCancer of Esophagus
Similarity Score9%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Cancer of EsophagusCarcinoma, Non-Small-Cell Lung
Similarity Score9%

Mark Levine, MD

Ontario Clinical Oncology Group (OCOG)

Related
13 trials

Shared therapeutic areas:

Cancer of EsophagusCarcinoma, Non-Small-Cell Lung
Similarity Score9%

David S Schrump, M.D.

National Cancer Institute (NCI)

Related
21 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungCancer of Esophagus
Similarity Score9%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell Lung

Worked with same sponsors:

Shenzhen Second People's Hospital
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT06125262PrincipalInvestigator

Trajectory Analysis of NLR and Its Association With Efficacy of Immunochemotherapy in ESCC.

ChemotherapyEsophageal Squamous Cell CarcinomaImmunotherapy
Unknown
NCT04822103PrincipalInvestigator

A Real-World Study of Immune Checkpoint Inhibitors and Chemotherapy for Advanced Esophageal Cancer

Esophageal Cancer
Completed
NCT05637580StudyDirector

Pathological Tumor and Lymph Node Responses After Neoadjuvant Immunochemotherapy in Initially-unresectable NSCLC

ChemotherapyImmunotherapyNon Small Cell Lung Cancer+1 more
Completed
NCT05596890Phase 2PrincipalInvestigator

Patient-reported Outcomes in Preoperative Immunochemotherapy/Radiotherapy-treated Esophageal Cancer Patients

Esophageal Squamous Cell CarcinomaImmunotherapyPatient-reported Outcomes
Unknown
NCT06012318PrincipalInvestigator

Dynamic Follow-up of Symptoms Based on Patient-reported Outcomes in Immunotherapy for Esophageal Cancer: a Prospective Multicentre Cohort Study (SPRING)

Esophageal CancerImmunotherapyPatient-reported Outcomes
Unknown

All 5 trials loaded